• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Inflammatory Breast Cancer International Consortium | IBC-IC HomepageInflammatory Breast Cancer International Consortium | IBC-IC

  • IBC Researchers + Centers
  • What is IBC?
  • About Us
  • Join IBC-IC
  • Research + Clinical Trials
  • Contact Us
  • Donate

< Back to Search Results

Paul Lavine, MD, FACP, ACE

Paul Levine, MD, FACP, ACE

Researcher

Title(s)

  • Research Professor, University of Nebraska Medical Center
  • Director, Inflammatory Breast Cancer Registry
  • Guest Worker, Infection and Immunoepidemiology Branch, National Cancer Institute

Location(s)

  • College of Public Health
  • 984395 Nebraska Medical Center
  • University of Nebraska Medical Center
  • Omaha, NE, 68198
  • United States of America
  • Phone: 402.559.4248

Research and Clinical Interests

  • Biochemistry
  • Biostatistics
  • Epidemiology
  • Inflammatory Breast Cancer
  • Molecular Biology

Education and Board Certifications

MD

University of Rochester Medical School, Rochester, New York (1963)

Internship

Strong Memorial Hospital, University of Rochester, Rochester, New York (1964)

Residency

Roswell Park Memorial Institute, Buffalo, New York (1966)

Residency

University of Colorado Medical Center, Denver, Colorado (1968)

Board Certification(s)

American Board of Internal Medicine, National Board of Medical Examiners

Years in Practice

54

Affiliations and Memberships

  • American Association for Chronic Fatigue Syndrome
  • American College of Physicians
  • American Association for Cancer Research
  • American College of Epidemiology
  • International Association for Breast Cancer Research
  • International Retrovirology Association: HTLV
  • District of Columbia Cancer Registry Advisory Board

Recent Publications

Prognostic value of lymphocyte vascular density and e-cadherin in inflammatory breast cancer
Journal of Cancer Therapy; 2014

Initial response to chemotherapy, not delay in diagnosis, predicts overall survival in inflammatory breast cancer
American Journal of Clinical Oncology; 2012

Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and e-cadherin in distinguishing inflammatory from locally advanced breast cancer
Clinical Breast Cancer; 2012

What is inflammatory breast cancer? Revisiting the case definition
Cancers; 2010

Join IBC-IC

Become part of our international consortium of researchers, clinicians, advocates and centers worldwide dedicated to ending IBC.

Join >

IBCIC.org makes every effort to keep researcher information as up-to-date as possible.
Contact this researcher to confirm any information regarding his or her profile.

Footer

Inflammatory Breast Cancer International Consortium
420 E 70th St, LH 206
New York, NY 10021

Contact us

contact@ibcic.org